Search in:

Oncolytic Virotherapy Volume 9, 2020 - Issue

Journal homepage

Open access

404

Views

CrossRef citations to date

Altmetric

Review

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

Nadishka Jayawardena1 Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand

John T Poirier2 Department of Medicine and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

https://orcid.org/0000-0001-9795-5644

Laura N Burga1 Department of Microbiology and Immunology, University of Otago, Dunedin, New ZealandCorrespondence[email protected] [email protected]

Mihnea Bostina1 Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand;3 Otago Micro and Nano Imaging, University of Otago, Dunedin, New Zealand

https://orcid.org/0000-0003-3621-3772

Pages 1-15 | Published online: 06 Mar 2020

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (19)

Henry Sossa-Rojas, Pedro Gabriel Franco-Maz, Carlos Zapata-Acevedo, Luz Dary Gutierrez-Castañeda & Carlos Guerrero. (2023) Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma. PLOS ONE 18:5, pages e0285543.
Crossref

Maya A. Dymova, Anna S. Kichkailo, Elena V. Kuligina & Vladimir A. Richter. (2022) Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy. Pharmaceutics 15:1, pages 151.
Crossref

Mehdi Shahgolzari, Hassan Dianat-Moghadam & Steven Fiering. (2022) Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies. Seminars in Cancer Biology 86, pages 1076-1085.
Crossref

Ofek Mussafi, Jie Mei, Wenjun Mao & Yuan Wan. (2022) Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer. Frontiers in Oncology 12.
Crossref

Andrew R. Swartz, Yvonne Shieh, Amanda Gulasarian, Jessica W. Olson & Richard R. Rustandi. (2022) Binding of Coxsackievirus A21 procapsids to immobilized glutathione depends on cell culture conditions during infection. Virology 573, pages 167-175.
Crossref

S. Feola, S. Russo, E. Ylösmäki & V. Cerullo. (2022) Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment. Pharmacology & Therapeutics 236, pages 108103.
Crossref

Spyridon Konstantinidis, Murphy R. Poplyk, Andrew R. Swartz, Richard R. Rustandi, Rachel Thompson & Sheng-Ching Wang. (2022) Application of cation exchange chromatography in bind and elute and flowthrough mode for the purification of enteroviruses. Journal of Chromatography A 1676, pages 463259.
Crossref

Harrison M. McCann, Benjamin P.M. Lake, Kyle S. Hoffman, Maria E. Davola, Karen L. Mossman & Anthony F. Rullo. (2022) Covalent Immune Proximity-Induction Strategy Using SuFEx-Engineered Bifunctional Viral Peptides. ACS Chemical Biology 17:5, pages 1269-1281.
Crossref

Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina O. Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohamad, Faroogh Marofi, Navid Shomali, Amir Zamani & Morteza Akbari. (2022) Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell International 22:1.
Crossref

Michalina Bartak, Marcin Chodkowski, Anna Słońska, Marta Grodzik, Jarosław Szczepaniak, Marcin W. Bańbura & Joanna Cymerys. (2022) Equid Alphaherpesvirus 1 Modulates Actin Cytoskeleton and Inhibits Migration of Glioblastoma Multiforme Cell Line A172. Pathogens 11:4, pages 400.
Crossref

Seyed-Mahmood Seyed-Khorrami, Hoorieh Soleimanjahi, Sara Soudi & Ala Habibian. (2021) MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice. Cancer Cell International 21:1.
Crossref

Natalia Vasileva, Alisa Ageenko, Maria Dmitrieva, Anna Nushtaeva, Sergey Mishinov, Galina Kochneva, Vladimir Richter & Elena Kuligina. (2021) Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma. Life 11:10, pages 1084.
Crossref

Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref

Ali Ahmadi, Hadi E.G. Ghaleh, Ruhollah Dorostkar, Mahdieh Farzanehpour & Masoumeh Bolandian. (2021) Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review. Current Cancer Therapy Reviews 17:3, pages 173-178.
Crossref

Alicia Teijeira Crespo, Stephanie Burnell, Lorenzo Capitani, Rebecca Bayliss, Elise Moses, Georgina H. Mason, James A. Davies, Andrew J. Godkin, Awen M. Gallimore & Alan L. Parker. (2021) Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity. Immunology 163:4, pages 389-398.
Crossref

Gang Cheng, Hui Dong, Chen Yang, Yang Liu, Yi Wu, Lifen Zhu, Xiangmin Tong & Shibing Wang. (2021) A review on the advances and challenges of immunotherapy for head and neck cancer. Cancer Cell International 21:1.
Crossref

Guendalina Froechlich, Chiara Gentile, Luigia Infante, Carmen Caiazza, Pasqualina Pagano, Sarah Scatigna, Gabriella Cotugno, Anna Morena D’Alise, Armin Lahm, Elisa Scarselli, Alfredo Nicosia, Massimo Mallardo, Emanuele Sasso & Nicola Zambrano. (2021) Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing. International Journal of Molecular Sciences 22:2, pages 477.
Crossref

Chang-Myung Oh, Hong Jae Chon & Chan Kim. (2020) Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors. International Journal of Molecular Sciences 21:20, pages 7743.
Crossref

David M. Morens & Anthony S. Fauci. (2020) Emerging Pandemic Diseases: How We Got to COVID-19. Cell 182:5, pages 1077-1092.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

Articles from other publishers (19)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

Citations (19)

Articles from other publishers (19)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date